Logo 5313 750 Pill - white oval, 18mm
Pill with imprint Logo 5313 750 is White, Oval and has been identified as Ciprofloxacin Hydrochloride 750 mg. It is supplied by Teva Pharmaceuticals USA.
Ciprofloxacin is used in the treatment of Bacterial Infection; Bacteremia; Anthrax; Anthrax Prophylaxis; Typhoid Fever and belongs to the drug class quinolones and fluoroquinolones. Risk cannot be ruled out during pregnancy. Ciprofloxacin 750 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo 5313 750
Ciprofloxacin Hydrochloride
- Imprint
- Logo 5313 750
- Strength
- 750 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Quinolones and fluoroquinolones
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00172-5313 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (6 mPa.s),
hypromellose 2910 (50 mPa.s),
magnesium stearate,
microcrystalline cellulose,
polydextrose,
polyethylene glycol 8000,
corn starch,
sodium starch glycolate type A potato,
magnesium silicate,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
More about ciprofloxacin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (927)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: quinolones and fluoroquinolones
- Breastfeeding
Patient resources
- Ciprofloxacin drug information
- Ciprofloxacin injection
- Ciprofloxacin (Intravenous) (Advanced Reading)
- Ciprofloxacin (Oral) (Advanced Reading)
- Ciprofloxacin Extended-Release Tablets
Other brands
Professional resources
- Ciprofloxacin monograph
- Cipro IV (FDA)
- Ciprofloxacin (FDA)
- Ciprofloxacin Extended Release Tablets (FDA)
- Ciprofloxacin Injection (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
